Lexeo Therapeutics, Inc. (LXEO)
(Delayed Data from NSDQ)
$4.76 USD
+0.03 (0.63%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $4.77 +0.01 (0.21%) 4:42 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Fundamental Charts
About Dividend Yield (TTM)
Lexeo Therapeutics, Inc.'s dividend yield currently sits at 0%, which is in-line with the Medical - Drugs industry's yield of 0.00%.
The company's trailing twelve month (TTM) Dividend Yield calculates the indicated annual dividend divided by the stock price. This value is always expressed as a percentage. This is the return on investment that is specifically attributed to the expected dividends that are paid out over a year. Note: investors should not base their investments on the size of the dividend yield alone. Seek attractive dividend yields, but only on top rated stocks with a solid payment history.
LXEO 4.76 +0.03(0.63%)
Will LXEO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for LXEO based on the 1-3 month trading system that more than doubles the S&P 500.
Other News for LXEO
This Lexeo Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Thursday
Meta, Microsoft upgraded: Wall Street's top analyst calls
Oppenheimer Initiates Coverage on Lexeo Therapeutics (LXEO) with Outperform Rating | LXEO Stock News
Lexeo Therapeutics (LXEO) Receives Positive Start by Oppenheimer
Lexeo Therapeutics initiated with bullish view at Oppenheimer, here's why